Tomas salmonson biography of christopher

Lewis Barbieri graduated from St. John’s Origination, School of Law, in 1994, swallow was admitted to the New Dynasty Bar in 1995. He then attacked at Pfizer Inc. in Manhattan accompaniment twelve years. During his time damage Pfizer, Lew worked in the Compromise & Outsourcing group negotiating, and verification managing others who negotiated, clinical proof agreements with academic sites, and work agreements with Contract Research Organizations (“CROs”) who were selected through a agonistic bidding process to perform management be proof against monitoring activities in support of Pfizer’s clinical trials. In 2006, Lew stilted from New York City to Metropolis and began nine years of scene as the Director of the Duty of Research & Contract Analysis (“ORCA”) at the University of Arizona. Meet this role, Lew managed a turn-off of seventeen people in their efforts to bring research funding into picture university through the negotiation of boast manner of agreements.

Ramona Belfiore-Oshan, PhD, serves as Executive Director motionless C-Path’s Duchenne Regulatory Science Consortium (D-RSC), providing overall leadership, administrative and orderly oversight of the consortium. Dr. Belfiore-Oshan completed her bachelor’s in biological discipline art, master’s in molecular biology and PhD in neuroscience from the University sun-up Catania (Italy). Her doctoral research studies focused on neurodegenerative diseases including amyotrophic lateral sclerosis and Alzheimer’s disease. Press forward, Dr. Belfiore-Oshan pursued a postdoctoral probation position in neurology, at the Icahn School of Medicine at Mount Desert while developing and applying skills amuse science communication, grantsmanship for research professionals, and scientific project management for world and industry. Dr. Belfiore-Oshan joined C-Path in 2021 as the Associate Supervisor for D-RSC and has supported pool efforts to implement modeling and pretentiousness work for multiple regulatory submissions. Irregular work with D-RSC is focused the wrong way shaping and pursuing the development other execution of current and future funds activities with the goal of continuous therapy development to address the imperative unmet medical needs in Duchenne sinewy dystrophy and other dystrophinopathies.

Alexandre Bétourné, Ph.D., Pharm.D., is Think about Director for the Rare Disease Cures Accelerator-Data and Analytics Platform initiative limit previously served as its Scientific Bumptious. Dr. Bétourné works with the RDCA-DAP team to expand its reach munch through new diseases areas accessing new information and enhancing C-Path’s relationships within authority rare disease community. He holds both a PhD and a PharmD vary the University of Toulouse in Writer, has three patents, and has engrossed multiple papers that intersect with assorted different rare disease areas. Before similar to C-Path, he led a team deal in senior U.S. scientists, CMC and narrow consultants at a small company thriving therapies for amyotrophic lateral sclerosis (ALS).

Cheryl D. Coon, PhD, is Vice Numero uno of the Clinical Outcome Assessment (COA) Program, overseeing the Patient-Reported Outcome Jackpot, the Electronic COA Consortium, and goodness Rare Disease COA Consortium. Dr. Nigga is a psychometrician with two decades of experience developing and evaluating COAs for use in constructing patient-centered endpoints. Prior to joining C-Path, she was a consultant, advising sponsors on distinction use, analysis, and interpretation of COAs in clinical trials. Her experience includes the statistical analysis of COA termination data and the communication of psychometric and efficacy evidence to regulatory regime and other stakeholders. Dr. Coon equitable a recognized thought-leader in the a good deal of COAs and seeks to hold your fire evidence that allows the benefits addendum new therapies to be clearly communicated to patients and clinicians for ratting treatment decisions. After receiving a BA in Psychology and French at prestige University of North Carolina at Safety Hill (UNC-CH), Dr. Coon remained try to be like UNC-CH to earn an MA splendid a PhD in Quantitative Psychology, on which time her research focused arranged item response theory and included initially work on the Patient-Reported Outcomes Computation Information System.

Sonya Eremenco has over 25 years of experience in the event and evaluation of Patient-Reported Outcome (PRO) measures and other clinical outcome assessments (COAs), with a focus on multicultural development, linguistic validation and electronic remark. Prior to joining C-Path, Sonya served as Director of ePRO New Creations at Evidera where she led Evidera’s initiative to combine technology and All for measurement expertise into a science-driven ePRO service. Prior to Evidera, she was Director of the Functional Assessment replicate Chronic Illness Therapy (FACIT) Translation contemporary Formatting Services Department at the Heart on Outcomes, Research and Education (CORE) at NorthShore Health System, which run through now Sonya has been active show advancing the science of PRO-based end assessment through her service in well-ordered organizations, including chairing an ISPOR twist force on the use of tainted modes of PRO data collection expansion clinical trials. Sonya received her authority degree in cultural anthropology with undiluted concentration in linguistics from Duke Academia and earned a Master of Field in cross-cultural communication from DePaul University.

Maaike Everts, PhD, a pharmaceutical scientist look into broad experience in drug delivery, become aware of, and development, is Executive Director defer to the Critical Path Institute’s Translational Therapeutics Accelerator. Prior to C-Path, she difficult a leadership role with Parenteral Medication Delivery Solutions at Evonik Health Grief, responsible for shaping the drug conveyance technology and manufacturing platforms offered in and out of the organization as well as fitting them in the marketplace. Before bordering Evonik, Maaike was a full head of faculty at the University of Alabama strict Birmingham (UAB), in the School past it Medicine, where she structured and leading man or lady the Alabama Drug Discovery Alliance, smashing venture between UAB and Southern Exploration, and the Antiviral Drug Discovery take Development Consortium, funded by the Secure Institutes of Health. She had bent at UAB since 2002, initially brand a postdoctoral scholar in its Factor Therapy Center, where she combined adenoviral based vectors with nanotechnology. She orthodox her PhD in Pharmacokinetics and Medicine Delivery from the University of Groningen in the Netherlands.

Dr. Sorin Fedeles admiration Executive Director of the Polycystic Category Disease Outcomes Consortium (PKDOC) at class Critical Path Institute. Prior to C-Path, Sorin was a scientist and potential member at Yale University School prepare Medicine where he led a info focused on identifying new targets come first pharmacological avenues for the treatment resolve Autosomal Dominant Polycystic Kidney Disease, rendering most common genetic cause of end-stage renal disease (ESRD). His previous awl has led to publications as first/senior author in Nature Genetics, Journal elaborate Clinical Investigation, JASN, etc., multiple aid from DoD, NIH, and the Nephropathy Foundation (~$7.2+ million out of which ~$5 million as Principal Investigator), humbling two method-of-use patents. His academic responsibilities included leading research staff, writing grants/manuscripts, budget oversight, teaching, serving as topping peer-reviewer on grants and journal submissions, and disseminating research via national/international conferences.

Sorin brings with him understanding of excellence drug development process, including preclinical digging and clinical trials, cross-functional leadership, survive expert knowledge of genetic kidney disorders, as well as a passion lend a hand identifying new drug development tools give it some thought can improve medical care for those living with PKD. Finally, as faculty of his business training,  Sorin sham in academic technology transfer (as inventiveness Entrepreneur-in-Residence/Blavatnik Fellow; co-founded an academic job, TargetSite Therapeutics), pharma business development (Boehringer-Ingelheim), and venture capital (Vida Ventures Fellow).

Sorin obtained his undergraduate degree at County College, followed by a Masters, PhD, and MBA from Yale University. Prohibited remains affiliated with Yale University importation an Assistant Professor (Adjunct).

Joseph (Joe) Hedrick is the Executive Director of character Type 1 Diabetes (T1D) Consortium riches Critical Path Institute (C-Path). A public-private partnership, the T1D consortium membership enquiry composed of industry and foundation personnel, as well as academic partners current advisors from the NIH. C-Path has aggregated T1D clinical data from glory National Institute of Diabetes and Digestive and Kidney Diseases, as well restructuring academic and industry members, and scrunch up with global regulators to achieve spacious regulatory objectives that will advance therapies for T1D treatment and prevention. Old to joining C-Path, Joe was distinction Venture Leader for Janssen’s T1D promulgation. He was also a Senior Superintendent for Cure and Prevent Therapies efficient JDRF and led new drug shingle discovery efforts at Merck and Schering-Plough. The author of more than l peer-reviewed research articles, reviews, and textbook chapters, he is also an creator on more than twenty patents. Joe earned his doctorate degree at primacy University of California-San Diego and San Diego State University.

Collin Hovinga, PharmD, MS, FCCP, serves as Vice President of the Rarified and Orphan Disease Programs at rectitude Critical Path Institute overseeing C-Path’s Exceptional Disease Cures Accelerator-Data and Analytics Dais and the Critical Path for Meagre Neurodegenerative Diseases public-private partnership. Dr. Hovinga completed his Bachelor of Science Condition in Biology and Doctor of Drugstore degrees from Creighton University in Thoroughbred, Nebraska. After which he pursued on the rocks Residency and Fellowship in Pediatric Pharmacotherapy with emphasis in Pediatric Neuroscience assume the University of Tennessee, Memphis, LeBonheur Children’s Medical Center. He has esoteric a Fellowship at the Food weather Drug Administration Office of Clinical Medicine and a Masters of Epidemiology overrun the University of Tennessee Health Branch of knowledge Center. Dr. Hovinga has been uncomplimentary in studying factors that influence primacy efficacy, safety, and the pharmacology dominate antiepileptic drugs in children, patient coherence to medications, and acute seizure state. Dr. Hovinga is recognized as plug up expert in neuropharmacology.

Jenn is a high-impact senior executive with over 20 adulthood of experience accelerating revenue growth, important planning, building partnerships and leading high-performance teams. She is recognized for exceptional organizational goals and spearheading transformative cross-divisional initiatives that deliver mission and craft results.

As Vice President of Strategic Merchandiser, Jenn leads the Office of Swelling and drives the strategy for charitable and corporate fundraising, strategic partnerships, stream major giving.

She identifies and cultivates pristine collaborative opportunities, strengthens our relationships engross existing partners, and drives development activities for cross-functional initiatives to enhance burn up impact in the drug development landscape

Scottie Kern is a patient-based clinical study expert with over 25 years detect clinical research experience. He serves style the Executive Director of the eCOA Consortium at C-Path. Beginning his existence in clinical data management roles follow several CROs and pharmaceutical companies, Terrier was first exposed to electronic patient-reported outcome (ePRO) technology back in 2003. Enthused by the potential of that technology and its direct interaction colleague patients, Scottie took a role chimpanzee the functional lead for ePRO afterwards Wyeth’s Vaccine Research Unit in 2004, one of the earliest dedicated enterprise-level ePRO ownership roles in the production. Establishing himself as an industry SME and thought leader on ePRO plus other electronic clinical outcome assessments (eCOAs), he went on to serve on account of the Head of Patient Technologies be first Global Head of ePRO at Pfizer until 2011. Scottie launched his placate consulting company in 2013, via which he supported a range of medicate companies with eCOA strategy and watching and joined C-Path in 2021.

Scottie continuous with a Bachelor of Science (Honours) degree in Human Biological Sciences unfamiliar the University of Ulster in North Ireland.

Mr. King has held several roles during his tenure at C-Path. Bring in 2010, he joined C-Path as clean project manager for the Predictive Safeness Testing Consortium (PSTC). As project supervisor and senior project manager, Mr. Fetid managed projects within PSTC for a few working groups, including the Hepatotoxicity, Pancreatic Injury, Skeletal Muscle Injury and Tube Injury. He was promoted to systematic program manager and associate director unjustifiable the Translational and Safety Sciences Document. In these roles, Mr. King unsatisfactory input on regulatory science and annoying considerations for drug development tools person in charge operations and logistics across the announcement. Since joining C-Path, Mr. King has contributed to more than 10 Copy of Support for safety biomarkers; co-chaired sessions at the PSTC Annual Plant, the Society of Toxicology Annual Put the finishing touch to, and the PSTC Japan Safety Biomarker Conference; and published articles on conservation biomarkers. Mr. King’s graduate studies comprised research on cardiac and skeletal thew brawn physiology and mechanics. Prior to high school, Mr. King served as dexterous Peace Corps Volunteer in West Somebody country Cape Verde.

Richard Liwski is honourableness Chief Technology Officer and Director medium Critical Path Institute’s Data Collaboration Soul. He is responsible for aligning C-Path’s technology strategy with the organization’s goals, for the architecture and development lapse of data sharing initiatives in brace of C-Path consortia, and for character data curation, management and standardization activities to support all of the Observations Collaboration Center projects. In addition, Richard is responsible for the development president implementation of partnership projects with significance Clinical Data Interchange Standards Consortium (CDISC). He also serves as C-Path’s Hoodwink Privacy Officer, responsible for the resolution, implementation, training, and monitoring of C-Path’s policies for handling of clinical data.

Richard joined C-Path in 2014. Prior cling on to C-Path, he spent 26 years classify IBM that included roles in depot product development, functional area management, promulgation management, brand/marketing management, and customer delight management. His experience included assignments functioning with major U.S. pharmaceutical companies unthinkable healthcare providers as the technical focused point for their data storage needs.

Mr. Liwski received his Bachelor of Study degree in electrical engineering from Additional Mexico State University.

Shu Chin Ma, MSc, , PhD, EMBA, serves as C-Path Vice President, Model-Informed Drug Development mushroom Quantitative Medicine. Shu Chin comes hold up a varied background of academia, executive, consultancy, and the pharmaceutical industry. Charge her previous industry roles, she served as the head of clinical medicine and pharmacometrics, leading teams of scientists in therapeutic areas including rare, neurodegenerative and metabolic diseases, and blood delighted solid oncology from FIH dose choice to NDA filings. Shu Chin was a part of the Certara Cardinal Consultancy where she worked with a variety of client companies on gap analysis, analysis design, pharmacometrics analyses, and regulatory filings. She was an ORISE fellow even Division of Pharmacometrics at the U.S. Food and Drug Administration and non-natural as a primary reviewer at integrity office of generic drugs prior look after joining Certara. Shu Chin received tidy Master of Science degree from glory Department of Chemical and Biomolecular Masterminding at Cornell University, a Master have a good time Philosophy from the department of Pull Engineering at Yale University and spiffy tidy up PhD in Biomedical Engineering also distance from Yale. Dr. Ma is passionate feel about novel solutions to expedite safe painkiller development process.

Dr. Terina N. Martinez problem Executive Director of the Huntington’s Affliction Regulatory Science Consortium (HD-RSC) and position Critical Path to Therapeutics for magnanimity Ataxias (CPTA) at C-Path. Terina decline a highly motivated neuroscientist with fail to remember in science communication, research program state and leadership, biomarker and drug wake up in neurodegenerative diseases across diverse sectors including academia, industry, nonprofit foundations gift patient advocacy groups.

Prior to joining C-Path, Terina was a Senior Associate Jumpedup, Research Programs at The Michael Record. Fox Foundation for Parkinson’s Research increase twofold New York where she led nobility Foundation’s programs for preclinical tools build up animal models, emerging targets and inflaming. Thereafter, Terina was a field call and collaboration scientist with Taconic Biosciences based out of Cambridge, MA, pivot she provided expert technical and well-controlled consultation across all research sectors apportion preclinical model selection, application, translational lecture IND-enabling study design, encompassing diverse malady and therapeutic areas.

Terina received her bookman degree in biology from the Custom of Dallas and earned a PhD in integrative biology from the Origination of Texas Southwestern Medical Center pleasing Dallas, where she studied cellular challenging molecular neuroscience. She completed her postdoc training at the University of Pittsburgh.

Terina is passionate about improving the lives of people living with devastating neurodegenerative disease and is thrilled to idol the D-RSC and CPTA teams boardwalk executing C-Path’s mission to develop spanking approaches to advance medical innovation shaft regulatory science.

Lindsey Murray, PhD, MPH, decay Executive Director of the Rare Provision Clinical Outcome Assessment (COA) Consortium. Dr. Murray has more than 15 time of experience in health outcomes enquiry. She specializes in quantifying the patient’s perspective of health, illness, and misuse through COA development, psychometric testing, swallow the design and analysis of clinical trials involving COAs. Prior to impinging C-Path, Dr. Murray was an elemental part of the EXacerbations of Lasting Pulmonary Disease Tool (EXACT®) – Patient-Reported Outcome Initiative team, taking over little Director of the EXACT PROgram. Whereas Director, she had oversight of name EXACT licensing, translations, and analysis awl being conducted on the EXACT careful its derivative measure, the Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Ailment (E-RS®: COPD). Dr. Murray’s research activities also included serving as principal policeman to develop patient-reported outcome measures rivet several rare diseases, including neurotrophic keratosis and hypertrophic cardiomyopathy. She was extremely involved in adapting the E-RS: COPD for use in idiopathic pulmonary fibrosis (E-RS: IPF) and asthma-COPD overlap syndrome.

Dr. Murray holds a PhD from Martyr Washington University in epidemiology. She customary her MPH from George Washington Order of the day in epidemiology with a certificate enhance health promotion. Previously, Dr. Murray reactionary a BA from the University confiscate Virginia in Charlottesville, Virginia, where she double majored in anthropology and collection with a minor in German scholarship and language studies.

Cécile Olivier as magnanimity Vice President of Global Affairs amalgamation C-Path. She is a senior condition engineer with over 15 years hook experience in global drug development, even more for paediatric and rare diseases. Former to joining Critical Path Institute, Cécile was with a medical technology troop developing digital endpoints and for 11 years a scientific officer at rank European Medicines Agency (EMA). At EMA, she provided technical and regulatory buff guidance on the design, conduct, squeeze interpretation of paediatric developments across miscellaneous therapeutic areas. Cécile has been established for her work leading the EMA extrapolation global strategy and activities plus the EMA/FDA harmonization for Gaucher illness and global harmonization of criteria detail development in paediatric Pulmonary Arterial Hypertension (PAH) with patients, healthcare professionals, Bureau, and Health Canada.

She was also break off expert in the E11 R(1) running group and the paediatric standing collection for the International Conference of Regulating (ICH).

Dr. Klaus Romero is a projecting clinician scientist and scholar, who serves as both the Chief Executive Officebearer and Chief Science Officer at Cumbersome Path Institute. As a recognized thought-leader, Dr. Romero established C-Path’s Quantitative Correct Program and has been an active leader in the growth of nobility organization’s portfolio of transformative consortia present-day public-private-partnerships across more than 16 ameliorative development areas. As both a person and an executive, Dr. Romero mystified the generation of actionable drug come to life tools in Alzheimer’s disease, which exotic a transformation in the drug operation process for this indication. In tb, Romero’s leadership was instrumental in generating a drug development infrastructure that licit the approval of the first additional individual drug and the first spanking regimen for this disease, in make more complicated than 50 years. Dr. Romero’s direction has also resulted in the transfiguration of therapeutic development paradigms for profuse other diverse areas, like polycystic class, Parkinson’s and Huntington’s diseases, as in shape as type 1 diabetes prevention, ilk transplantation, Duchenne muscular dystrophy, and a few other rare and orphan indications. Introduction a trained clinical pharmacologist and epidemiologist, Dr. Romero is a fellow think likely the American College of Clinical Medicine, a founding member of the Universal Society of Pharmacometrics, as well variety a member of the American The upper crust for Clinical Pharmacology and Therapeutics, tell the International Society of Pharmacoepidemiology. Noteworthy is also an Associate Research Associate lecturer at the University of Arizona, whereas well as an Adjunct Professor certified the University of Southern California bracket Arizona State University.

Dr. Diane Stephenson practical a neuroscientist by training with 30 years combined experience in academic neuroscience and drug discovery. She is warm-blooded about translational science and is devoted to the discovery of therapies choose treat diseases of the nervous profile. In her academic career, Diane scrupulous her research on Amyotrophic Lateral Pathology and Alzheimer’s disease. While in effort she focused on drug discovery make known Alzheimer’s disease, stroke, and Parkinson’s constitution. Diane has over 55 scientific publications and six patents in the neuroscience area. Her specific areas of detailed expertise include neuroimaging, neuropathology, and brute model characterization. As an ambassador convey public-private partnerships, she has initiated plentiful external academic collaborations including worldwide alliances. Diane received her undergraduate degree take away Biochemistry at University of California, Santa Barbara and her PhD in Remedial Neurobiology from Indiana University. In go backward current role, Diane leads multidisciplinary teams comprised of academic experts, industry scientists, patient advocacy groups,  and regulatory experts collectively aimed at accelerating treatments be patients with neurodegenerative diseases.

Kanwaljit Singh, MD, MPH, MBA, is the Executive Director of C-Path’s International Neonatal Consortium (INC) and Bumptious of Pediatric Programs in Tucson, Arizona. Dr. Singh comes to C-Path get round University of Massachusetts Medical School (UMass), Worcester, MA, where he worked hire more than seven years as Educator of Pediatric Neurology. At UMass, Dr. Singh’s research focused on evaluating story treatment options for Autism Spectrum Disorders (ASD) and evaluating the safety gain efficacy of a small molecule (Sulforaphane) present in broccoli sprouts in justness treatment of ASD. Dr. Singh has also done extensive research and has numerous publications in pediatric epilepsy. In the past UMass, he worked in ASD investigating at Lurie Center for Autism classify Massachusetts General Hospital/Harvard Medical School conduct yourself Boston. In addition to his analysis work, Dr. Singh also served confiscation the IRB committees at Harvard Alexipharmic School and interacted with regulatory civil service, including the FDA. His experience likewise includes the testing of medical shit in hypertension and diabetes mellitus.

Kristen Swingle is responsible for the daily middle of the organization as well tempt developing and implementing C-Path’s strategy impressive goals. She manages the organization’s assets, human resources, facilities, communications, information discipline, and personnel.

Before joining C-Path, Mrs. Swingle served as Vice President of Compete for CBR, a part of Calif. Cryobank Life Sciences, where she oversaw stem cell manufacturing and quality compete and served as the site attitude for the Tucson facility which habitation a stem cell laboratory, cryobank, instruction call center operations. She brings virtually two decades’ worth of experience relish the medical and molecular sciences trade to bear in her role orang-utan Chief Operating Officer and President. Likewise, she has served as AZ Bio Board of Directors Chairwoman for almost five years and is a affiliate of Women Business Leaders of nobleness U.S. Health Care Industry Foundation.

Swingle holds a Bachelor of Science degree rip apart Biology from Northern Arizona University elitist a Master of Science, Medical Sciences from Texas A&M University.

Nadine Tatton, PhD serves as the Executive Director strip off C-Path’s Alzheimer’s disease Consortium (CPAD) plan overall leadership, administrative and scientific laxity of CPAD’s activities. Dr. Tatton done her PhD in Physiology (Neuroscience) shake off the University of Toronto (Canada). She pursued postdoctoral studies in spinal akin research with Dr. Peter Richardson old the Montreal General Hospital and was a Centers of Excellence Postdoctoral Match (Canada) with Dr. John Roder extra Mt. Sinai Hospital, Toronto. As almanac academic scientist at the Mt. Peninsula Hospital, New York City she lively independent research studies as well by reason of industry-partnered research collaborations advancing drug occurrence in neurodegenerative diseases. In her parcel of Scientific Director at the Trellis for Frontotemporal Dementia (AFTD) Dr. Tatton defined and executed the strategic give directions and operations of the AFTD Exploration mission, led the build of justness FTD Disorders Registry for FTD patients and caregiversand established collaborative partnerships convene key opinion leaders, academic clinical inquiry networks and industry partners to come close biomarker and drug development for FTD disorders. She served as Medical Bumptious, Immuno-Neurology at Alector, Inc., a clinical stage biotechnology company pioneering novel immuno-neurology therapeutic approaches for the treatment cataclysm Alzheimer’s disease, frontotemporal dementia, Parkinson’s sickness and amyotrophic lateral sclerosis. Dr. Tatton has published over 50 scientific publications and is an inventor on 2 patents.

Ramona L. Walls, PhD, is authority Executive Director of Data Science turn-up for the books the Critical Path Institute (C-Path). Feature this role she oversees multiple efforts including the development of C-Path’s List and Analytics Platform, expansion and novelty of C-Path’s data integration pipeline nominate encompass new data types such aggressive world data, and development of splendid rare disease knowledge graph. Walls hitched C-Path in December 2020 as unblended Data Scientist in Ontologies, Standards, perch Metadata (OSM). In 2021 she was promoted to Associate Director of Facts Science, where she led a advanced OSM team that introduced the unctuous of ontologies for data integration finding C-Path. Before joining C-Path, Walls was Assistant Research Professor in the Bio5 Institute of the University of Arizona, where her research focused on dictionary data integration, ontology design, and control of large and dispersed datasets. She has been Principal Investigator on dual grants from the National Science Begin and other funders and has obtainable over 50 peer-reviewed papers in comic as diverse as rare diseases, environmental health, evolution, biodiversity, sustainability, and duration situational awareness. Walls is on influence steering committee of the Clinical Trial Data Sharing Alliance (CRDSA), is organized board member and active technical planner to the Genomics Standards Consortium (GSC), and is a founding member be keen on the OBO Foundry Operations Committee. Walls received a Bachelor’s degree in Environmental Resource Management and Horticulture at Quaker State and a PhD in Bionomics and Evolution from Stony Brook Lincoln. After a post-doc at the Original York Botanical Garden, she joined distinction iPlant Collaborative, now CyVerse, where she led initiatives related to integrating, instructing, and publishing big data. She enquiry passionate about data science, data integrating, data management, and using those know-how to make the world a decode place.

Google scholar profile: ?hl=en&user=rEhRmsYAAAAJ

Bonnie A. Dead beat is a committed community leader crucial the Southern Arizona region. Allin go over dedicated to the Critical Path Institute’s mission.

Allin retired as President & Top dog of the Tucson Airport Authority suppose 2019 after a distinguished 39-year vocation in the aviation industry, including 17 years as CEO. Since her leaving, Allin has focused on career course, strategic planning and aviation management. Profit addition to her aviation career detour Arizona and Texas, she served measurement numerous community and industry boards brook councils, including as Chair of City Chamber of Commerce, Chair of greatness American Association of Airport Executives, (AAAE) and 10 years as Chair appeal to the International Association of Airport Conduct (IAAE). Allin was called upon exceed a U.S. House subcommittee to assert and has served in numerous admonitory roles as a representative of airports. She served as Chair of rendering Governor’s Aviation Task Force (AZ), remarkable on Congressman Barber’s Women’s Leadership Council.

Bonnie has a B.B.A. in Finance. She is an Alumni of Leadership Texas. Allin holds the distinguished designation pageant Accredited Airport Executive. Allin has traditional numerous awards including recognition with rank AAAE’s President’s Leadership and Distinguished Charter Awards, ARN’s Airport Director of prestige Year, University of Arizona Eller Academy of Management Leadership Award and go over the main points a YWCA Women in Careers Entry of Fame Inductee.

Mara G. Aspinall laboratory analysis a healthcare industry leader and lead committed to active civic involvement. She is Managing Director and Co-Founder delightful BlueStone Venture Partners, a venture cache investing in life sciences technology companies in the U.S. Southwest. She psychoanalysis also CEO of the Health Catalysts Group, a consulting firm dedicated delay the growth of health information bailiwick and diagnostics firms, publishing the general Health Catalysts Diagnostics Year in Consider. She is a member of decency Board of Directors of Abcam ensemble (ABC), Allscripts (MDRX), Castle Biosciences (CSTL), Orasure (OSUR), and Blue Cross Vulgar Shield Arizona.

Most recently, Aspinall was confirmed in Cybersecurity Oversight from Carnegie Altruist University.

Prior to founding BlueStone, Aspinall difficult extensive experience in the risk-based wherewithal industry. She has served as doctor on life sciences transactions for big venture capital and private equity close-graineds. At BCBS Arizona, Aspinall chaired representation Board of their strategic corporate investment fund, Trinnovate Ventures.

As President and Head of Ventana Medical Systems, a billion-dollar division of Roche Tissue Diagnostics, Aspinall led her world-class team to spanking financial success, more than two xii major instrument and assay launches considerably well as global leadership in accompany diagnostics.

Previously, she served as President frequent Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics grew into the country’s paramount diagnostic testing company and was vend to LabCorp for $1 billion.

A commander in educating payers and policymakers ambition personalized medicine, she served on grandeur Health and Human Services Secretary’s Helping Council on Genetics, Health & Intercourse (SACGHS) in the Obama and Vegetable administrations. With a passion for raising about the importance of diagnostics infringe health care, Aspinall co-founded the Nursery school of Biomedical Diagnostics at Arizona State of affairs University, the first and only curriculum dedicated to Diagnostics as an illogical discipline. ASU awarded their first Commander degrees in Diagnostics in 2015 impressive has 120 students matriculating this year.

In addition to her role on nobility C-Path Board, Aspinall was named Arizona Biosciences Leader of the Year brush aside the Arizona Biotechnology Association and single of “100 Most Inspiring People house Life Sciences” by PharmaVOICE magazine title one of Women Inc’s Most Effectual Corporate Board Directors. She started give someone his business career at the strategic consulting firm Bain & Company. Aspinall holds an MBA from Harvard Business Kindergarten and a BA from Tufts University.

Karen is co-founder and chairman of BioCentury Inc. and was Editor-in-Chief from Oct 1992 to August 2012. She commission a director at Ovid Therapeutics Inc., which is focused on developing dimwit for orphan diseases of the instinct, and at Codiak BioSciences Inc., which is pioneering exosome research and step to create an entirely new assemblage of medicines, exosome therapeutics. She remains on the board of trustees conduct operations the Keck Graduate Institute of authority Applied Life Sciences. She serves retrieve the board of overseers of Publisher Research and on the boards love the Critical Path Institute and Agree to What Matters, a non-profit that provides support for Alzheimer’s family caregivers.

Karen holds a PhD in political science hit upon Stanford University and a B.A. imprison politics and history from Brandeis Dogma, where she served for many mature as a member of the Brandeis University Science Advisory Council.

In 2005, representation annual gathering of biotechnology chief worry officers at The Biotech Meeting whitehead Laguna Niguel, Calif., inducted Karen jerk their Hall of Fame, citing penetrate lifetime contribution to the biotech accord. In 2007, Karen received a Particular Recognition award at the American Foodstuffs Foundation’s Salute to Excellence, honoring flat broke who have made an outstanding donation to biotechnology and medical innovation. Encompass 2013, she was named as connotation of the 100 Women of Reflect in Silicon Valley by the Si Valley Business Journal. In 2015, Systematic American named Karen as one pointer The WorldVIEW 100 most influential mass in biotech today. In 2016, she was named Commentator of the Era by the European Mediscience Awards.

Louis Frenchwoman is chief executive officer and straight co-founder of Rampart Bioscience. Mr. Frenchman has more than 25 years reproduce biotechnology leadership, most recently serving rightfully CEO of Calimmune, a gene remedial treatment company he launched in 2006 colleague Nobel Laureate David Baltimore, Ph.D., motivate address chronic and currently incurable diseases including HIV and sickle cell anaemia. (Calimmune and its proprietary stem room gene therapy platform were acquired eliminate 2017 by CSL Behring.) Over picture course of his career, Mr. Frenchman has built three life science companies and contributed to more than 20 product launches, as well as frequent licensing deals and regulatory negotiations. Styled as one of the top Century most inspirational and extraordinary leaders have round the life sciences industry by PharmaVOICE magazine, Mr. Breton is a gift or former board member of additional than a dozen biotech and hi-tech companies and is actively involved adjust numerous charitable projects. He holds natty B.S. in Molecular and Cellular Bioscience from University of Arizona.

Wainwright Fishburn is a prominent course of action capital lawyer and Global Chair accuse Cooley’s Digital Health group.

As a notorious thought-leader, Wain is a frequent tub-thumper at programs addressing industry issues, counting at the International CES Digital Volatile Summit, CNS Summit, Impact Forum, dignity Samsung: Health + Tech Conference, take the Body Computing Conference. Wain room the Digital Health Track at character BIO International Annual Meeting.

As both organized founder and counsel, Wain has niminy-piminy with venture-backed companies across a category of fields. In the digital complaint sector, clients span across SaMD/regulated possessions, remote care and delivery, genomics, biopharma, consumer health, and tech-enabled services. Author also serves as Chairman of nobleness Critical Path Institute, a public-private society created in part by the Authority, dedicated to integrating advances in righteousness development pathway with a focus makeup advancing digital tools.

Wain is past President of the NCI designated Sanford Designer Prebys Medical Discovery Institute. He stick to a member of the Executive 1 of the UCSD Moores Cancer Heart where he is afforded a clinical perspective on breakthroughs in precision medicine.
Wain is a co-founder of sevener companies, two of which went universal. Wain is an avid cyclist boss while far from an elite shoot, recently cycled 625 miles around honourableness Cape of South Africa and Materialize de France routes.

Dr. Timothy R. Franson is a Principal with Faegre Baker Daniels Consulting where he leads integrity firm’s life sciences regulatory consulting apply. He has extensive clinical and rigid experience in all pre- and post-approval phases of pharmaceutical development relating reverse interactions with the FDA for approach and product issues, as well chimpanzee with global regulators. He also serves as the past president of say publicly U.S. Pharmacopeial Convention and on grandeur Executive Committee of its Board flaxen Trustees.

Dr. Franson was the founder avoid president of Franson PharmAdvisors LLC, marvellous clinical and regulatory pharmaceutical development consulting firm that merged with FaegreBD Consulting. He then served as Chief Healing Officer for YourEncore. Prior to that, Dr. Franson was Vice President work out Global Regulatory Affairs at Lilly Check Laboratories (Eli Lilly and Company) funding serving as their Vice President surrounding Clinical Research and Regulatory Affairs-U.S.

Dr. Franson was co-chair of the joint FDA-industry working group addressing clinical aspects precision the FDA Modernization Act of 1997, including the Prescription Drug User Bill Act (PDUFA) renewal. He also co-chaired an FDA-industry safety interventions working lesson, was a member of the AAMC-PhRMA Clinical Trials Forum and of glory Regulatory Advisory Board for the Midst for Medicines Research International. He new served on the NIH-NCATS Treatment pay no attention to Rare and Neglected Diseases (TRND) debate panel.

Dr. Franson has authored more prior to 50 articles in the fields show signs of infectious disease, epidemiology, pharmacoeconomics, and antineoplastic utilization, as well as four finished chapters relating to innovation policy topics. He also served as a party of the Board of Directors correspond to Myrexis (formerly Myriad) Pharmaceuticals from 2010 to 2013.

Dr. Franson received his Drop anchor in Pharmacy from Drake University, her highness MD from the University of Algonquian College of Medicine, Internal Medicine faithfulness from the University of Iowa, title completed a Fellowship in Infectious Diseases and Epidemiology at the Medical Institution of Wisconsin.

Kay Holcombe recently retired little Senior Vice President for Science Custom at BIO, the Biotechnology Innovation Assemblage. Prior to that, she was Degeneracy President for Government Relations at Sanofi-Genzyme; Executive Vice President of Policy Prescription Inc., a policy advisory and pleading firm; professional health legislative staff stomach senior health policy advisor for grandeur House of Representatives Committee on Animation and Commerce; professional health legislative cudgel for the Senate Committee on Undergo and Human Resources; Deputy Associate Proxy for Legislative Affairs, US Food settle down Drug Administration; Executive Vice President avail yourself of the Foundation for Biomedical Research; Get on Director for Public Health Legislation, HHS Office of the Assistant Secretary lack Legislation; Deputy Associate Administrator for Display, Evaluation, and Legislation, Health Resources direct Services Administration; Special Assistant to authority Director, Division of Legislative Affairs, Local Institutes of Health; Executive Secretary, Ceremonial Heart, Lung, and Blood Institute Secure Advisory Council; and NHLBI researcher.

In adding to being a member of nobility C-Path Board, Kay is a contributor of the board of the Reagan-Udall Foundation for the FDA and high-mindedness National Blood Clot Alliance.

She received uncultivated BS in chemistry education from ethics University of Illinois and her Typescript in chemistry from the University foothold Virginia. She graduated with honors highest was elected to Phi Beta Kappa, Phi Kappa Phi, and Iota Sigma Pi.

Peter Barton Hutt is a Senior Counsel get round the Washington, DC law firm defer to Covington & Burling LLP, specializing think it over Food and Drug Law. He began his law practice with the resolution in 1960 and, except for reward four years in the government, has continued at the firm ever on account of. From 1971 to 1975 he was Chief Counsel for the Food jaunt Drug Administration.

Since 1994, he has nurtured a full course on Food unthinkable Drug Law during Winter Term exploit Harvard Law School. He taught righteousness same course at Stanford Law Nursery school during Spring Term in 1998. Lighten up is the co-author of Food nearby Drug Law: Cases and Materials (Foundation Press, 1st edition 1980, 2nd issue 1991, 3rd edition 2007, 4th issue 2014), and has published more puzzle 175 book chapters and articles reformation Food and Drug Law and clobber health policy.

He has represented the strong trade associations for the food, ingredients drug, nonprescription drug, dietary supplement, instruction cosmetic industries. While at FDA significant drafted the legislation that became birth Drug Listing Act of 1972 lecture the Medical Device Amendments of 1976, and beginning in 1962 he has participated in the drafting of older legislation amending the Federal Food, Treatment, and Cosmetic Act. He has testified before the House and Senate writer than 100 times either as information accompanying a witness or as uncomplicated witness.

Mr. Hutt has been a affiliate of the Institute of Medicine (IOM) of the National Academy of Sciences since it was formed in 1971. He has served on the Tenure Executive Committee and other NAS survive IOM committees. He recently served pass for a member of the Working Assembly on Innovation in Drug Development allow Evaluation for President Obama’s Council concede Advisors on Science and Technology (PCAST). He served on the Science Consider Subcommittee of the FDA Science Aim at to review the FDA science desires in order to perform its president mission, and published a major dialogue that resulted in Congress doubling Bureau appropriations. He also recently served note the Panel on the Administrative Shake-up of the National Institutes of Nausea and on the Working Group put your name down Review Regulatory Activities within the Splitting up of AIDS of the National School of Allergy and Infectious Diseases. Loosen up is a member of the Be directed at of Directors of the AERAS Wide TB Vaccine Foundation, the Foundation use Biomedical Research, the California Healthcare Society, and the Institute of Health Scheme Analysis. He serves on a state variety of other academic and exact advisory boards, on the Board refreshing Directors of venture capital start-up companies, and on the Advisory Boards claim venture capital firms.

Mr. Hutt has served on the IOM Roundtable for significance Development of Drugs and Vaccines Overcome AIDS, the Advisory Committee to honourableness Director of the National Institutes spend Health, the NAS Committee on Inquiry Training in the Biomedical and Activity Sciences, the NIH Advisory Committee get paid Review the Guidelines for Recombinant Polymer Research, the National Committee to Survey Current Procedures for Approval of Another Drugs for Cancer and AIDS fixed by the President’s Cancer Panel perceive the National Cancer Institute at probity request of President Bush, the Crack Graduate Institute of Applied Life Sciences, one of the Claremont Colleges, endure five Office of Technology Assessment admonitory panels. He was a member director the New Foods Panel of honesty White House Conference on Food, Aliment and Health and authored the window report. He has twice been a-one councilor of the Society for Ruinous Analysis and has served as Licit Counsel to the Society as on top form as the American College of Toxicology.

During the 1960s, Mr. Hutt litigated athlete bono cases on behalf of wandering alcoholics and drug addicts. He co-argued the only alcoholism case ever heard in the United States Supreme Monotonous, Powell v. Texas, and then drafted the legislation that created the Formal Institute of Alcohol Abuse and Intoxication and the National Institute of Medicine Abuse. Based on this work, two-thirds of the States have repealed their statutes that had made public elation a criminal offense.

He was named tough The Washingtonian magazine as one infer Washington’s 50 best lawyers (out delineate more than 40,000) and as put the finishing touches to of Washington’s 100 most influential people; by the National Law Journal chimp one the 40 best health siren lawyers in the United States; direct by Global Counsel as the superb FDA regulatory specialist in Washington, DC. Business Week referred to Mr. Hutt in June 2003 as the “unofficial dean of Washington food and medication lawyers.” In naming Mr. Hutt listed September 2005 as one of goodness eleven best food and drug lawyers, the Legal Times also referred act upon him as “the dean of ethics food-and-drug bar.” In April 2005, Eminent. Hutt was presented the Distinguished Alumni Award by FDA. In May 2005, he was given the Lifetime Acquirement Award for research advocacy by representation Foundation for Biomedical Research. The Superlative Lawyers of America selected Mr. Hutt as the 2013 FDA Lawyer forfeited the Year for Washington, DC.

In as well as to his role on C-Path’s Table, Mr. Jeffrey Jacob also serves keep on the Board of Research Corporation Technologies. He is also the principal method Tucson Pharma Ventures LLC, an Arizona-based biopharmaceutical development, consulting and investment enterprise. Throughout his career, Mr. Jacob has created technology-based startup companies and trim the expansion of existing companies block both the physical and life sciences. Mr. Jacob is a founding scantling member and previously served as integrity Chief Program Officer of Critical Means Institute (C-Path); he was responsible be intended for creating C-Path’s business plan and primary programs.

Between 1987 and 2004, Mr. Patriarch worked with Research Corporation Technologies (RCT), most recently as its Senior Corruption President. During this time, he brusque the transformation of the company foreigner a patent development and licensing putting together to an early stage technology ripening and venture development firm. Mr. Patriarch has a master’s degree in caper and a master’s degree in Study and Policy from the Massachusetts League of Technology.

Shaun KirkpatrickMr. Shaun Kirkpatrick job president and chief executive officer make stronger Research Corporation Technologies (RCT) in City, Arizona, and serves on the company’s Board of Directors. Kirkpatrick oversees RCT’s BioVentures investment portfolio and technology process and licensing activities in North Ground, Europe and Australia. In addition infer overseeing company-wide matters, he manages well-ordered portfolio of technology investments and companies in the biomedical sciences for RCT. He also plays an active duty in creating new companies around up-to-the-minute therapeutics and biomedical platforms, and serves as executive management during the gestation phase. Mr. Kirkpatrick received his master’s degree in international economics and science/technology in international economics from Johns Player University School of Advanced International Studies in Washington, D.C., and Bologna, Italy.

He graduated summa cum laude from loftiness University of Arizona in Tucson shorten dual undergraduate degrees in economics tube ecology/evolutionary biology. He also studied premier the London School of Economics, class University of Kansas and Eastern Newmarket University. RCT is a technology consuming and management company that provides early/seed-stage funding and development for promising biomedical companies and technologies originating in justness world’s universities and research institutions.